Glucocorticoid-induced diabetes
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Developing set patients admitted in Department of General Internal Medicine, Gifu University Hospital between 1 June 2004 and 31 July 2016. Validation set A: admitted in Department of General Internal Medicine, Gifu Prefectural General Medical Center between 1 April 2012 and 31 July 2016. B: admitted in Center of General Internal Medicine and Rheumatology, Gifu Municipal Hospital between 1 April 2012 and 31 July 2016. Inclusion criteria applied to the Developing set, and Validation set A and B indicate that patients were 20 years of age or older and the glucocorticoid treatment with the dosage of prednisolone more than 5 mg/day for 4 weeks at least was administered for the first time.
Exclusion criteria
Exclusion criteria: Exclusion criterion indicates taking concomitantly anti-cancer drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Administration of insulin therapy during glucocorticoid treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Administration of oral hypoglycemic agentsand glucagon like peptide 1 receptor agonist | — |
Countries
Japan
Contacts
Gifu University Hospital Department of General Internal Medicine